Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

RNASEH2A anticorps

L’anticorps Lapin Polyclonal anti-RNASEH2A a été validé pour WB et IF. Il convient pour détecter RNASEH2A dans des échantillons de Humain et Rat.
N° du produit ABIN6568584

Aperçu rapide pour RNASEH2A anticorps (ABIN6568584)

Antigène

Voir toutes RNASEH2A Anticorps
RNASEH2A (Ribonuclease H2, Subunit A (RNASEH2A))

Reactivité

  • 23
  • 4
  • 4
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Humain, Rat

Hôte

  • 22
  • 4
Lapin

Clonalité

  • 25
  • 1
Polyclonal

Conjugué

  • 23
  • 1
  • 1
  • 1
Cet anticorp RNASEH2A est non-conjugé

Application

  • 22
  • 12
  • 11
  • 6
  • 5
  • 5
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Immunofluorescence (IF)
  • Purification

    Affinity purification

    Immunogène

    Recombinant fusion protein of human RNASEH2A (NP_006388.2).

    Isotype

    IgG
  • Indications d'application

    WB 1:500-1:2000 IF 1:50-1:200

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1 mg/mL

    Buffer

    PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    -20 °C

    Stockage commentaire

    Store at -20°C. Avoid freeze / thaw cycles.
  • Antigène

    RNASEH2A (Ribonuclease H2, Subunit A (RNASEH2A))

    Autre désignation

    RNASEH2A

    Sujet

    The protein encoded by this gene is a component of the heterotrimeric type II ribonuclease H enzyme (RNAseH2). RNAseH2 is the major source of ribonuclease H activity in mammalian cells and endonucleolytically cleaves ribonucleotides. It is predicted to remove Okazaki fragment RNA primers during lagging strand DNA synthesis and to excise single ribonucleotides from DNA-DNA duplexes. Mutations in this gene cause Aicardi-Goutieres Syndrome (AGS), a an autosomal recessive neurological disorder characterized by progressive microcephaly and psychomotor retardation, intracranial calcifications, elevated levels of interferon-alpha and white blood cells in the cerebrospinal fluid.

    Poids moléculaire

    Observed_MW: 33kDa

    Calculated_MW: 33kDa

    ID gène

    10535

    UniProt

    O75792
Vous êtes ici:
Chat with us!